Skip to Main Content

Paper Details

Safety, pharmacokinetics, and pharmacodynamics of a next-generation subcutaneously administered coagulation factor IX variant, dalcinonacog alfa, in previously treated hemophilia B patients.
J Thromb Haemost
6
2021

Datasets

Release 1.2